By Monya Baker of Nature magazine The first company to test a human embryonic stem-cell product in patients has become the first big player to bail out of the field. [More]
Excerpt from:
Pioneering Stem-Cell Therapy Research Halted
If you enjoyed this post, make sure you subscribe to my RSS feed!